BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10920947)

  • 1. [Surgical treatment of perplexing renal cell carcinoma].
    Lin Z; Chen S; Ye C
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):463-4. PubMed ID: 10920947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transabdominal radical nephrectomy for renal cell carcinoma: an experience on 155 patients].
    Chen XF; Zhou FJ; Han H; Qin ZK; Liu ZW; Yu SL; Li YH; Wang H; Hou GL
    Ai Zheng; 2007 May; 26(5):528-32. PubMed ID: 17672946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal cell carcinoma with regional lymph node metastasis].
    Kitamura Y; Watanabe M; Komatsubara S; Sakata Y
    Hinyokika Kiyo; 1995 Jun; 41(6):433-8. PubMed ID: 7645451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of radical nephrectomy for renal cell carcinoma. Report 1. Analysis according to the TNM staging system of the general rule for clinical and pathological studies on renal cell carcinoma].
    Nishio Y; Nishimura K; Hida S; Okada Y; Takeuchi H; Miyakawa M; Okada K; Yoshida O
    Hinyokika Kiyo; 1987 Mar; 33(3):337-43. PubMed ID: 3618401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy.
    Boorjian SA; Crispen PL; Lohse CM; Leibovich BC; Blute ML
    J Urol; 2008 Jul; 180(1):99-103; discussion 103. PubMed ID: 18485415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node involvement in renal cell carcinoma and survival chance by systematic lymphadenectomy.
    Schafhauser W; Ebert A; Brod J; Petsch S; Schrott KM
    Anticancer Res; 1999; 19(2C):1573-8. PubMed ID: 10365148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic versus open partial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate.
    Permpongkosol S; Bagga HS; Romero FR; Sroka M; Jarrett TW; Kavoussi LR
    J Urol; 2006 Nov; 176(5):1984-8; discussion 1988-9. PubMed ID: 17070227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of primary-tumor extension, stage and grade of nuclear differentiation in patients with renal cell carcinoma.
    Fiori E; De Cesare A; Galati G; Bononi M; D'Andrea N; Barbarosos A; Izzo L; Bolognese A
    J Exp Clin Cancer Res; 2002 Jun; 21(2):229-32. PubMed ID: 12148583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassessing the current TNM lymph node staging for renal cell carcinoma.
    Terrone C; Cracco C; Porpiglia F; Bollito E; Scoffone C; Poggio M; Berruti A; Ragni F; Cossu M; Scarpa RM; Rossetti SR
    Eur Urol; 2006 Feb; 49(2):324-31. PubMed ID: 16386352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal cell carcinoma in children. Prognostic factors.
    Al-Shabanah MO; Jenkin DR; Khafaga YO; Al-Zahrani AM; Danjoux C; Greenberg M
    Saudi Med J; 2004 Nov; 25(11):1583-6. PubMed ID: 15573183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal cell carcinoma (hypernephroid carcinoma)].
    Wandschneider G; Pummer K
    Z Urol Nephrol; 1986 Aug; 79(8):433-9. PubMed ID: 3776365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of radical nephrectomy associated with regional lymphadenectomy for renal cell carcinoma].
    Igarashi T; Murakami S; Hara S; Tanaka M; Oki T; Isaka S; Okano T; Abe K; Shimazaki J; Matsuzaki O
    Hinyokika Kiyo; 1991 Sep; 37(9):975-80. PubMed ID: 1785423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
    Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection.
    Pantuck AJ; Zisman A; Dorey F; Chao DH; Han KR; Said J; Gitlitz BJ; Figlin RA; Belldegrun AS
    J Urol; 2003 Jun; 169(6):2076-83. PubMed ID: 12771723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoreductive surgery for stage IV renal cell carcinoma.
    Bennett RT; Lerner SE; Taub HC; Dutcher JP; Fleischmann J
    J Urol; 1995 Jul; 154(1):32-4. PubMed ID: 7776449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
    Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
    J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma.
    Capitanio U; Jeldres C; Patard JJ; Perrotte P; Zini L; de La Taille A; Ficarra V; Cindolo L; Bensalah K; Artibani W; Tostain J; Valeri A; Zigeuner R; Méjean A; Descotes JL; Lechevallier E; Mulders PF; Lang H; Jacqmin D; Karakiewicz PI
    BJU Int; 2009 Jan; 103(1):33-7. PubMed ID: 18990161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
    Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
    J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of clinicopathological parameters in patients treated for renal cell carcinoma.
    Dall'Oglio MF; Arap MA; Antunes AA; Cury J; Leite KR; Srougi M
    J Urol; 2007 May; 177(5):1687-91. PubMed ID: 17437783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.